4//SEC Filing
Shmagin Martin E 4
Accession 0001013762-09-000324
CIK 0000932352other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:24 PM ET
Size
7.7 KB
Accession
0001013762-09-000324
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-02-24$0.12/sh+1,000$120→ 3,123,573 total - Purchase
Common Stock, $.001 Par Value
2009-02-25$0.10/sh+1,500$150→ 3,125,073 total - Purchase
Common Stock, $.001 Par Value
2009-02-25$0.12/sh+1,000$120→ 3,126,073 total
Documents
Issuer
Urigen Pharmaceuticals, Inc.
CIK 0000932352
Entity typeother
Related Parties
1- filerCIK 0001407236
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:24 PM ET
- Size
- 7.7 KB